贝斯美(300796) - 2020 Q2 - 季度财报

Financial Performance - The company's operating revenue for the reporting period was ¥180,020,984.28, a decrease of 37.71% compared to ¥289,017,700.55 in the same period last year[21]. - The net profit attributable to shareholders of the listed company was ¥12,380,466.98, down 68.35% from ¥39,115,809.92 in the previous year[21]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥13,211,169.87, a decrease of 65.54% compared to ¥38,334,770.19 in the same period last year[21]. - The net cash flow from operating activities was ¥18,123,257.31, down 60.07% from ¥45,388,592.23 in the previous year[21]. - Basic earnings per share were ¥0.10, a decline of 76.74% from ¥0.43 in the same period last year[21]. - The diluted earnings per share were also ¥0.10, reflecting a 76.74% decrease compared to ¥0.43 in the previous year[21]. - The weighted average return on net assets was 1.23%, down 5.74% from 6.97% in the previous year[21]. - The company's operating revenue for the reporting period was ¥180,020,984.28, a decrease of 37.71% compared to ¥289,017,700.55 in the same period last year, primarily due to the impact of the pandemic on sales volume[55]. - The operating cost decreased by 34.45% to ¥133,246,292.26 from ¥203,273,341.42, also attributed to reduced sales volume due to the pandemic[55]. - The gross profit margin for pesticide intermediates and dimethomorph raw materials was 25.98%, down by 3.64% year-on-year[57]. - Research and development investment decreased by 22.62% to ¥12,058,494.59 from ¥15,582,615.62, reflecting the impact of the pandemic[57]. - The company reported a net profit loss of 7.94 million CNY from its subsidiary Jiangsu Yong'an during the reporting period due to the impact of the COVID-19 pandemic[87]. Assets and Liabilities - Total assets at the end of the reporting period were ¥1,193,761,351.10, a slight decrease of 0.42% from ¥1,198,791,073.40 at the end of the previous year[21]. - The company's current assets totaled CNY 752,868,935.38, down from CNY 796,245,029.33 at the end of 2019, indicating a decrease of approximately 5.5%[159]. - Cash and cash equivalents decreased significantly from CNY 485,277,103.96 at the end of 2019 to CNY 297,256,228.47, representing a decline of about 38.7%[158]. - Short-term borrowings increased from CNY 42,046,840.20 at the end of 2019 to CNY 90,101,803.54, reflecting an increase of approximately 114.5%[160]. - The total liabilities decreased from CNY 189,421,031.60 at the end of 2019 to CNY 181,808,100.72, a reduction of about 4.3%[160]. - The company's non-current assets increased from CNY 402,546,044.07 at the end of 2019 to CNY 440,892,415.72, marking an increase of approximately 9.5%[159]. - The total equity attributable to shareholders of the parent company increased to CNY 1,001,344,237.10 from CNY 998,434,546.01 at the end of 2019[164]. Research and Development - Research and development investment reached 12.06 million yuan, accounting for 6.7% of total revenue, with a total of 50 authorized patents, including 10 invention patents and 40 utility model patents[49]. - The company’s research and development focus is on environmentally friendly, efficient, and low-toxicity pesticides, aligning with national industrial policies[32]. - The company has developed a low-cost synthesis process for the insecticide Methomyl using by-products from the production of Dichloropropene[28]. - The company has successfully optimized production processes, leading to a significant reduction in by-product generation and overall production costs[40]. - The company plans to continue investing in R&D to enhance its core competitiveness and develop new products[89]. Production Capacity and Operations - The company has a production capacity of 8,000 tons of 4-nitro-ortho-xylene, 9,000 tons of N-(1-ethylpropyl)-3,4-dimethylbenzene, and 4,000 tons of 2,3-dimethylbenzene, positioning it among the leaders in the industry[33]. - The company’s subsidiary, Jiangsu Yong'an, has an annual production capacity of 12,000 tons of 95% dichloropropene and 4,000 kiloliters of 330 g/L emulsifiable concentrate[33]. - The company has developed a continuous production process for key intermediates and active ingredients, significantly improving production efficiency and reducing waste emissions[44]. - The company has become a leading global supplier of dimethenamid-P, achieving a full industry chain operation during the reporting period[89]. Market and Customer Relations - The company has established stable long-term relationships with numerous domestic and international clients, enhancing its market influence and competitive advantage[42]. - The company's top five customers accounted for 59.02% of total sales revenue, indicating a high customer concentration risk[90]. - The company’s overseas sales accounted for 59.15% of its main revenue, exposing it to foreign exchange fluctuation risks[96]. - The COVID-19 pandemic has posed challenges to market growth, prompting the company to optimize its product offerings and enhance customer satisfaction[88]. Environmental and Safety Compliance - The company has implemented a comprehensive wastewater treatment system to ensure legal and compliant discharge[127]. - The company has introduced advanced foreign waste gas treatment devices to enhance its waste gas management capabilities[127]. - The company reported no significant environmental violations, with all pollutant emissions within regulatory limits[125][126]. - The company has established a standardized hazardous waste temporary storage facility to manage solid waste properly[127]. - The company has established emergency response plans for environmental incidents, with documentation filed with local environmental authorities[130]. Corporate Governance and Shareholder Information - The financial report was approved by the board on August 27, 2020, indicating ongoing corporate governance practices[200]. - The total number of ordinary shareholders at the end of the reporting period was 12,752[140]. - Major shareholders include Ningbo Beisimei Investment holding 27.23% and Jiaxing Baohang Equity Investment holding 10.18%[140]. - The company did not undergo any changes in its controlling shareholder or actual controller during the reporting period[142]. - There were no significant litigation or arbitration matters during the reporting period[106].